التداخل بين كاربامازيبين وسيليجيلين

Concomitant use of monoamine oxidase inhibitors (MAOIs).

Before beginning treatment with EQUETRO, MAOIs should be discontinued for a minimum of 14 days.

Concomitant use with monoamine oxidase inhibitors (MAOIs) or use within 14 days of discontinuing an MAOI ( 4 )

Pharmacodynamic Drug Interactions M onoamine O xidase I nhibitors Concomitant treatment with EQUETRO is contraindicated during use of an MAOI or within 14 days after discontinuing an MAOI.

Drugs that induce CYP3A4 (e.g., phenytoin, carbamazepine, nafcillin, phenobarbital, and rifampin) should be used with caution.

Drugs that Induce CYP450 Adequate studies have not been done investigating the effect of CYP3A4 inducers on selegiline.